CN Patent

CN108030767B — 一种骨化三醇注射液及其制备方法

Assigned to Henan Taifeng Biotechnology Co ltd · Expires 2020-07-24 · 6y expired

What this patent protects

本发明公开了一种骨化三醇注射液及其制备方法，每1000mL的注射液由以下重量份数的原料组成：0.001‑0.002份骨化三醇、0.05‑0.55份的抗坏血酸、2‑20份的抗氧化剂、2‑20份助溶剂、10‑200份物理稳定剂、5‑50份的血管刺激调节剂、余量为注射用水。本发明骨化三醇注射液稳定性良好，可工业化生产。

USPTO Abstract

本发明公开了一种骨化三醇注射液及其制备方法，每1000mL的注射液由以下重量份数的原料组成：0.001‑0.002份骨化三醇、0.05‑0.55份的抗坏血酸、2‑20份的抗氧化剂、2‑20份助溶剂、10‑200份物理稳定剂、5‑50份的血管刺激调节剂、余量为注射用水。本发明骨化三醇注射液稳定性良好，可工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108030767B
Jurisdiction
CN
Classification
—
Expires
2020-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Henan Taifeng Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.